Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bone Biomarkers in Hemophilia A
NCT02306694Phase 3Completed
- Sponsor
- Oregon Health & Science University
- Start
- Dec 2014
- Primary completion
- Apr 2018
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of recombinant human coagulation factor VIII in hemophilia A, sponsored by Oregon Health & Science University. Started Dec 2014; status: completed.
02
Drugs
recombinant human coagulation factor VIII
03
Conditions
hemophilia A
Beyond the preview
Go deeper on NCT02306694.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02306694.